Michael J. McGeachie
- Physiology top 5%
- Asthma and respiratory diseases 43
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 9
- Neonatal Respiratory Health Research 7
- Immunology top 10%
- IL-33, ST2, and ILC Pathways 16
- Immunology and Allergy top 10%
- Cancer Research top 10%
- MicroRNA in disease regulation 15
-
- Metabolomics and Mass Spectrometry Studies 10
-
- Genetic Associations and Epidemiology 9
-
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- Scott T. WeissJessica Lasky‐SuKelan G. TantisiraJoanne E. SordilloAnn Chen WuRachel S. KellyAmber DahlinAugusto A. Litonjua
- Partner nations
- United StatesDenmarkBelgium
In The Last Decade
Michael J. McGeachie
71 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 125
- Physiology 713
- Pulmonary and Respiratory Medicine 400
- Immunology 252
- Immunology and Allergy 69
- Cancer Research 167
Countries citing papers authored by Michael J. McGeachie
This map shows the geographic impact of Michael J. McGeachie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. McGeachie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. McGeachie more than expected).
Fields of papers citing papers by Michael J. McGeachie
This network shows the impact of papers produced by Michael J. McGeachie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. McGeachie. The network helps show where Michael J. McGeachie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael J. McGeachie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 14 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 42 | |
| 17 | 2019 | 57 | |
| 18 | 2018 | 64 | |
| 19 | 2018 | 35 | |
| 20 | 2016 | 49 |
About Michael J. McGeachie
Michael J. McGeachie is a scholar working on Physiology, Cancer Research and Immunology, having authored 74 papers that have together received 1.6k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (43 papers), IL-33, ST2, and ILC Pathways (16 papers), MicroRNA in disease regulation (15 papers), Metabolomics and Mass Spectrometry Studies (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Genetic Associations and Epidemiology (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Neonatal Respiratory Health Research (7 papers). The work is most often cited by research in Physiology (713 citations), Pulmonary and Respiratory Medicine (400 citations) and Immunology (252 citations). Michael J. McGeachie has collaborated with scholars based in United States, Denmark and Belgium. Frequent co-authors include Scott T. Weiss, Jessica Lasky‐Su, Kelan G. Tantisira, Joanne E. Sordillo, Ann Chen Wu, Rachel S. Kelly, Amber Dahlin, Augusto A. Litonjua, Weiliang Qiu and Alvin T. Kho.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.